Combining our deep knowledge of biology with innovative technologies, AbbVie is committed to supporting education of scientific advances for those living with and treating widespread and debilitating cancers. \n
Oncology is a rapidly changing area. It is important to provide resources to help patients and healthcare providers navigate the evolving landscape of blood cancers and solid tumors.
\n
We provide educational support in the following areas:
\n
\n- Staying abreast of the rapidly evolving cancer landscape and science;
\n- Understanding the importance and relevance of biomarkers and cytogenetic testing;
\n- Developing and enhancing skills aimed at a meaningful co-management of disease; and
\n- Improving communication between patients and care team members
\n
\n
We will consider requests in the following areas:
\n
Hematologic Malignancies
\n
\n- Acute Myeloid Leukemia
\n- Chronic Lymphocytic Leukemia
\n- Multiple Myeloma
\n- Myelofibrosis
\n- Other Hematologic Malignancies
\n
\n
Solid Tumors
\n
\n- Non-Small Cell Lung Cancer
\n
\n"}}" id="text-17cee281bf" class="cmp-text">
结合我们的生物学与创新技术的深入了解,AbbVie致力于支持教育的科学进步和治疗广泛和衰弱的癌症。
肿瘤是一个快速发展的领域。重要的是要提供资源来帮助病人和卫生保健提供者导航血液肿瘤和实体肿瘤的发展格局。
我们提供教育支持在以下领域:
- 保持一致的快速发展的癌症景观和科学;
- 理解生物标记和细胞遗传学测试的重要性和相关性;
- 发展和加强技能针对疾病的一个有意义的共管;和
- 提高患者和护理团队成员之间的沟通
我们将考虑要求在以下领域:
血液恶性肿瘤
- 急性髓系白血病
- 慢性淋巴细胞白血病
- 多发性骨髓瘤
- 骨髓纤维化
- 其他血液恶性肿瘤
实体肿瘤